29 January 2018

Amedeo Smart

Independent Medical Education

Subscriber: th..@boehringer-ingelheim.com

HIV Infection

29 January 2018 | n=30

  1. Liu G, Sharma M, Tan N, Barnabas R, et al.
    HIV-positive women have higher risk of HPV infection, precancerous lesions, and cervical cancer: a systematic review and meta-analysis.
    AIDS 2018.

  2. Andersson E, Nordquist A, Esbjornsson J, Flamholc L, et al.
    Increase in transmitted drug resistance in migrants from Sub Saharan Africa diagnosed with HIV-1 in Sweden.
    AIDS 2018.

  3. Billioux VG, Grabowski MK, Ssekasanvu J, Reynolds SJ, et al.
    HIV viral suppression and geospatial patterns of HIV antiretroviral therapy treatment facility use in Rakai, Uganda.
    AIDS 2018.

  4. Defilippi C, Lo J, Christenson R, Grundberg I, et al.
    Novel mediators of statin effects on plaque in HIV: a proteomics approach.
    AIDS 2018.

  5. Sortino O, Richards E, Dias J, Leeansyah E, et al.
    IL-7 treatment supports CD8+ MAIT cell restoration in HIV-1 infected patients on ART.
    AIDS 2018.

  6. Hargreaves JR, Krishnaratne S, Mathema H, Lilleston PS, et al.
    Individual and community-level risk factors for HIV stigma in 21 Zambian and South African communities: analysis of data from the HPTN071 (PopART) study.
    AIDS 2018.

  7. Thomsen D, Erikstrup C, Jespersen S, Medina C, et al.
    The influence of HLA-types on disease progression among HIV-2 infected patients in Guinea-Bissau.
    AIDS 2018.

  8. Mulligan N, Best BM, Wang J, Capparelli EV, et al.
    Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIV.
    AIDS 2018.

  9. Justice AC, Gordon K, Skanderson M, Edelman EJ, et al.
    Non antiretroviral polypharmacy and adverse health outcomes among HIV-infected and uninfected individuals.
    AIDS 2018.

  10. de Silva TI, Leligdowicz A, Carlson J, Garcia-Knight M, et al.
    HLA-associated polymorphisms in the HIV-2 capsid highlight key differences between HIV-1 and HIV-2 immune adaptation.
    AIDS 2018.

  11. Carrico AW, Cherenack EM, Roach ME, Riley ED, et al.
    Substance-associated elevations in monocyte activation among methamphetamine users with treated HIV infection.
    AIDS 2018.

  12. Smit M, Olney J, Ford NP, Vitoria M, et al.
    The growing burden of non-communicable disease among persons living with HIV in Zimbabwe.
    AIDS 2018.

  13. Logerot S, Rancez M, Charmeteau-de Muylder B, Figueiredo-Morgado S, et al.
    HIV reservoir dynamics in HAART-treated poor immunological responder patients under IL-7 therapy.
    AIDS 2018.

  14. Rossi C, Saeed S, Cox J, Vachon ML, et al.
    Hepatitis C virus cure does not impact kidney function decline in HIV co-infected patients.
    AIDS 2018.

  15. DeJesus E, Haas B, Segal-Mauer S, Ramgopal M, et al.
    Superior Efficacy and Improved Renal and Bone Safety After Switching From a Tenofovir Disoproxil Fumarate (TDF)- to a Tenofovir Alafenamide (TAF)-based Regimen Through 96 Weeks of Treatment.
    AIDS Res Hum Retroviruses 2018.

  16. Murphy RA, Hatlen T, Moosa MY.
    Enhanced fluconazole consolidation therapy for cryptococcal meningitis in sub-Saharan Africa: Much to gain, little to lose.
    AIDS Res Hum Retroviruses 2018.

  17. Ndashimye E, Avino M, Kyeyune F, Nankya I, et al.
    Absence of HIV-1 drug resistance mutations supports the use of dolutegravir in Uganda.
    AIDS Res Hum Retroviruses 2018.

  18. .
    Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs.
    Clin Infect Dis 2018.

  19. Kenyon C.
    Risks of antimicrobial resistance in N. gonorrhoeae associated with intensive screening programs in PrEP programs.
    Clin Infect Dis 2018.

  20. Jenness SM, Weiss KM, Goodreau SM, Gift T, et al.
    Moving Forward with Treatment of Gonorrhea for Users of HIV Preexposure Prophylaxis Given the Threat of Antimicrobial Resistance.
    Clin Infect Dis 2018.

  21. Hosseinipour MC, Kang M, Krown SE, Bukuru A, et al.
    As-Needed versus Immediate Etoposide Chemotherapy in Combination with Antiretroviral Therapy for Mild or Moderate AIDS-associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial.
    Clin Infect Dis 2018.

  22. Crockett KB, Rice WS, Turan B.
    Associations Between Multiple Forms of Discrimination and Tobacco Use Among People Living with Hiv: The Mediating Role of Avoidance Coping.
    J Acquir Immune Defic Syndr 2018.

  23. Springer SA, Di Paola A, Azar M, Barbour R, et al.
    Extended-Release Naltrexone Improves Viral Suppression among Incarcerated Persons Living with HIV with Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized Trial.
    J Acquir Immune Defic Syndr 2018.

  24. Webel AR, Moore SM, Longenecker CT, Currie J, et al.
    A Randomized Controlled Trial of the Systemchange Intervention on Behaviors Related to Cardiovascular Risk in Hiv+ Adults.
    J Acquir Immune Defic Syndr 2018.

  25. Rawat A, Uebel K, Moore D, Yassi A, et al.
    Integrated Hiv-Care into Primary Care Clinics and the Influence on Diabetes and Hypertension Care: An Interrupted Time Series Analysis in Free State, South Africa Over Four Years.
    J Acquir Immune Defic Syndr 2018.

  26. Huang SH, Ren Y, Thomas AS, Chan D, et al.
    Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells.
    J Clin Invest 2018.

  27. Overbaugh J.
    Defining the barriers to women publishing in high-impact journals.
    J Virol 2018.

  28. Torrents de la Pena A, de Taeye SW, Sliepen K, LaBranche CC, et al.
    Immunogenicity in rabbits of SOSIP trimers from clades A, B and C, given individually, sequentially or in combinations.
    J Virol 2018.

  29. Martin EG, Schackman BR.
    Treating and Preventing HIV with Generic Drugs - Barriers in the United States.
    N Engl J Med 2018;378:316-319.

  30. Makadzange AT, Dougherty L, Birri R, Kupakuwana G, et al.
    Temporal Improvements in Long-Term Outcome in Care Among HIV Infected Children Enrolled in Public ART Care: An Analysis of Outcomes From 2004-2012 in Zimbabwe.
    Pediatr Infect Dis J 2018.

Display articles in

Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:

Amedeo HIV Infection

Five-Week Literature

18 February 2019

11 February 2019

04 February 2019

28 January 2019

21 January 2019

29 January 2018

Multidisciplinary Journal Club

  1. Kojic EM, Kang M, Cespedes MS, Umbleja T, et al.
    Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Women.
    Clin Infect Dis. 2014.

  2. Bassler D, Shinwell ES, Hallman M, Jarreau PH, et al.
    Long-Term Effects of Inhaled Budesonide for Bronchopulmonary Dysplasia.
    N Engl J Med. 2018;378:148-157.

  3. Cowell AN, Istvan ES, Lukens AK, Gomez-Lorenzo MG, et al.
    Mapping the malaria parasite druggable genome by using in vitro evolution and chemogenomics.
    Science. 2018;359:191-199.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016